1592 (abacavir): do not rechallenge after hypersensitivity reaction.
James
J S
JS
D019380:Anti-HIV Agents / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D015224:Dideoxynucleosides / Q000009:adverse effects* / Q000627:therapeutic use; D004342:Drug Hypersensitivity; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000099227:Abacavir
D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir